CLINICAL_TRIALS
trial_result
· 2025-03-10
Clinical Trial Update: A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection [Phase 3]
Summary
Phase 3 randomized trial evaluating prevention of recurrent community-associated MRSA skin infections has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: loren g miller | Conditions: Methicillin Resistant Staphylococcus Aureus Skin Infections | Phase 3 | Status: COMPLETED